Online citations, reference lists, and bibliographies.
← Back to Search

Biodegradable Polymer Based Particulate Carrier(s) For The Delivery Of Proteins And Peptides

N. Mishra, A. Goyal, K. Khatri, B. Vaidya, R. Paliwal, S. Rai, Abhinav Mehta, Shailja Tiwari, Shiva Vyas, S. P. Vyas
Published 2008 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Construction of safe and effective delivery systems for proteins and peptides is demand of current clinical practices. Biodegradable polymers based particulates carriers fulfill much of the requirement in this applicable field. Number of marketed products related to biodegradable polymers encapsulating proteins is increasing. However, it has not achieved its proper place since problems related to the protein processing and stabilization limits the scientific community. In this present review we have summarized various aspects related to the formulation and processing of biodegradable polymerized microparticles/ nanoparticles for delivery of therapeutic proteins and peptides. A brief introduction of biodegradable polymers has been incorporated for readers benefit. In addition, biodegradable polymers based carriers designed for vaccine delivery has been incorporated in detail. Functionalized biodegradable carrier(s) for site specific delivery of proteineous matter has also been discussed.
This paper references
10.1002/JBM.820170602
Structure-biocompatibility relationship of condensation polymers.
Y. Imai (1983)
10.1021/MA950707J
Microbial Polyester Synthesis: Effects of Poly(ethylene glycol) on Product Composition, Repeat Unit Sequence, and End Group Structure†
F. Shi (1996)
10.1159/000129507
Physical, biological and handling characteristics of surgical suture material: a comparison of four different multifilament absorbable sutures.
E. Debus (1997)
10.1080/10611860701637982
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
P. Gupta (2007)
10.1615/CRITREVTHERDRUGCARRIERSYST.V22.I5.10
Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
S. Galindo-Rodriguez (2005)
10.1001/ARCHSURG.1966.01330050143023
Polylactic Acid for Surgical Implants
R. K. Kulkarni (1966)
10.1007/978-1-4899-1236-7
Stability and Characterization of Protein and Peptide Drugs
Y. Wang (1993)
10.1016/S0378-5173(02)00461-1
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.
M. H. El-Shabouri (2002)
10.1615/CRITREVTHERDRUGCARRIERSYST.V12.I1.10
Biodegradable microspheres in drug delivery.
H. Okada (1995)
10.3109/02652049109021233
Association of cyclosporin to isohexylcyanoacrylate nanospheres and subsequent release in human plasma in vitro.
S. Bonduelle (1992)
10.1016/0142-9612(87)90121-9
Resorbable materials of poly(L-lactide). VII. In vivo and in vitro degradation.
J. Leenslag (1987)
10.1016/S0168-3659(97)00081-3
Effect of polymer crystallinity on papaverine release from poly (l-lactic acid) matrix
M. Miyajima (1997)
10.1016/S0168-3659(97)00203-4
Design of microencapsulated chitosan microspheres for colonic drug delivery.
M. L. Lorenzo-Lamosa (1998)
10.1016/S0264-410X(01)00162-1
Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered beta-amyloid in mice.
D. Brayden (2001)
Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers.
S. Takada (1995)
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
V. Lee (1991)
10.1016/S0141-3910(00)00031-8
Synthesis, characterization and degradation of ABA block copolymer of l-lactide and ε-caprolactone
Haitao Qian (2000)
10.1016/S0264-410X(99)00427-2
Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers.
B. Baras (2000)
10.1016/S0032-3861(98)00110-4
Aliphatic polyester-grafted starch-like polysaccharides by ring-opening polymerization
P. Dubois (1999)
10.1016/0168-3659(96)01368-5
Co-polymerised peptide particles II: Oral uptake of a novel co-polymeric nanoparticulate delivery system for peptides
A. M. Hillery (1996)
10.1021/BI00367A014
Why does ribonuclease irreversibly inactivate at high temperatures?
S. Zale (1986)
10.3109/10611869608995624
Oral protein drug delivery.
W. Wang (1996)
10.1016/0020-711x(92)90058-9
Biodegradable polymers as drug delivery systems
M. Chasin (1990)
10.1016/S0939-6411(98)00015-0
Preparation and characterization of nanoparticles containing an antihypertensive agent.
M. Leroueil-Le Verger (1998)
10.1016/S0168-3659(03)00337-7
Encapsulation of Ole e 1 in biodegradable microparticles induces Th1 response in mice: a potential vaccine for allergy.
E. Batanero (2003)
10.1038/86715
A biodegradable polymer as a cytokine delivery system for inducing bone formation
N. Saito (2001)
10.1016/J.BIOMATERIALS.2005.03.016
Chitosan: a versatile biopolymer for orthopaedic tissue-engineering.
A. Di Martino (2005)
10.1088/0960-1317/10/1/311
Microfabrication technology for polycaprolactone, a biodegradable polymer
D. Armani (2000)
10.1016/J.BIOMATERIALS.2004.07.047
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
S. Balthasar (2005)
10.1016/S0168-3659(00)00302-3
Dextrans for targeted and sustained delivery of therapeutic and imaging agents.
R. Mehvar (2000)
10.1016/J.BIOMATERIALS.2003.08.069
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
M. Ravi Kumar (2004)
10.1002/JPS.2600841202
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice.
J. C. Leroux (1995)
10.1016/0378-5173(89)90100-2
One-month release injectable microspheres of leuprolide acetate inhibit steroidogenesis and genital organ growth in rats
Hiroaki Okada (1989)
10.1016/0169-409X(92)90004-A
(D) Routes of delivery: Case studies
A. Boer (1992)
10.1163/156856206777996880
Formulation, characterization and release studies of alginate microspheres encapsulated with tetanus toxoid
M. Tafaghodi (2006)
10.1016/0300-9629(93)90342-2
Peptide and protein drug delivery
V. Lee (1991)
10.1111/j.2042-7158.1997.tb06085.x
Characterization of the Block Structure and Molecular Weight of Sodium Alginates
F. Johnson (1997)
Body distribution in mice of intravenously injected radiolabelled cyclosporin associated with polyisohexyl-cyanoacrylate nanocapsules or nanospheres
S. Bonduelle (1995)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.1016/0378-5173(94)00386-J
Using microemulsion formulations for oral drug delivery of therapeutic peptides
J. M. Sarciaux (1995)
10.1016/S0378-5173(01)00679-2
Release kinetics and immunogenicity of parvovirus microencapsulated in PLA/PLGA microspheres.
E. Pálinkó-Biró (2001)
10.1002/JAB.770060308
Reinforced poly(L-lactic acid) fibres as suture material.
K. H. Lam (1995)
10.1016/S0167-7799(99)01345-1
'Smart' polymers and what they could do in biotechnology and medicine.
I. Galaev (1999)
10.1159/000128335
Behaviour of synthetic absorbable sutures with and without synergistic enteric infection.
C. Kapadia (1983)
10.1007/s002620050499
Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres
J. Ma (1998)
10.1016/S0169-409X(01)00197-1
Chitosan for mucosal vaccination.
I. M. van der Lubben (2001)
10.1016/S0168-3659(99)00228-X
Lectin-mediated drug delivery: the second generation of bioadhesives.
C. Lehr (2000)
10.1016/S0168-3659(99)00073-5
Preparation and characterization of protein C-loaded PLA nanoparticles.
M. Zambaux (1999)
10.1016/S0264-410X(98)00323-5
Biodegradable microspheres containing influenza A vaccine: immune response in mice.
A. Hilbert (1999)
10.1081/DDC-100000124
Polymeric Controlled Drug-Delivery Systems: Perspective Issues and Opportunities
M. N. R. Ravi Kumar (2001)
10.1002/1097-4636(20010915)56:4<600::AID-JBM1133>3.0.CO;2-I
A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats.
J. Cadée (2001)
10.1016/S0142-9612(00)00278-7
Oriented Schwann cell growth on micropatterned biodegradable polymer substrates.
C. Miller (2001)
10.1016/S0264-410X(98)00008-5
Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
T. Greenway (1998)
10.1016/S0169-409X(00)00136-8
Responsive polymeric delivery systems.
J. Kost (2001)
10.1111/j.2042-7158.1997.tb06090.x
Oral Delivery and Fate of Poly(lactic acid) Microsphere‐encapsulated Interferon in Rats
J. Eyles (1997)
10.1016/0928-0987(94)90054-X
New aspects of pharmaceutical dosage forms for controlled drug delivery of peptides and proteins
H. P. Merkle (1994)
10.1016/0378-5173(81)90009-0
Effect of surfactants on the nasal absorption of insulin in rats
Hirai Shinichiro (1981)
10.1016/S0264-410X(00)00433-3
Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
M. Conway (2001)
10.1021/CR940351U
Polymeric systems for controlled drug release.
K. Uhrich (1999)
10.1021/JS9800782
FDA perspective on peptide formulation and stability issues.
C. Niu (1998)
10.1016/S0168-3659(98)00021-2
In vitro release of trypanocidal drugs from biodegradable implants based on poly(ε-caprolactone) and poly(d,l-lactide)
Y. Lemmouchi (1998)
10.1128/IAI.65.3.853-857.1997
Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.
K. Allaoui-Attarki (1997)
10.1016/J.BIOMATERIALS.2004.06.032
Study of gelatin-containing artificial skin V: fabrication of gelatin scaffolds using a salt-leaching method.
S. B. Lee (2005)
10.1006/JSRE.2000.6042
Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study.
U. Izhar (2001)
10.1016/S0169-409X(97)00055-0
Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata.
Anderson (1997)
10.1016/0168-3659(94)90073-6
Pharmacokinetics and pharmacodynamics of recombinant proteins and peptides
N. B. Modi (1994)
Tissue concentration of nanoencapsulated radio-labelled cyclosporin following peroral delivery in mice or ophthalmic application in rabbits
S. Bonduelle (1996)
10.1016/S0927-796X(01)00035-3
Polymeric biomaterials for tissue and organ regeneration
Brandon L Seal (2001)
10.1016/j.addr.2012.09.004
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Shive (1997)
10.1023/A:1024470508758
Visualization of Insulin-Loaded Nanocapsules: In Vitro and in Vivo Studies After Oral Administration to Rats
H. Pinto-Alphandary (2004)
10.3748/WJG.V10.I1.112
Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.
J. Chen (2004)
Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
C. Lehr (1994)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
10.1023/A:1011991617857
Soluble Self-Assembled Block Copolymers for Drug Delivery
G. Kwon (2004)
10.1016/J.VACCINE.2003.08.043
Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy.
V. Ferro (2004)
10.1016/S0264-410X(01)00508-4
Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
J. Rosas (2002)
10.1023/A:1015804816582
Bioadhesion by Means of Specific Binding of Tomato Lectin
C. Lehr (2004)
10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
Mechanical behavior of injection-molded starch-based polymers
R. Reis (1996)
10.1016/S0169-409X(97)00122-1
Protein release from polyphosphazene matrices.
Payne (1998)
10.1016/0168-3659(95)00051-9
The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method
J. Herrmann (1995)
10.1016/S0169-409X(98)00012-X
Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.
Gupta (1998)
10.1016/S1461-5347(98)00059-5
Pharmaceutical applications of chitosan
V. Dodane (1998)
10.1016/S0032-3861(98)00549-7
Enzymatic degradation of poly(ε-caprolactone)/poly(dl-lactide) blends in phosphate buffer solution
Z. Gan (1999)
10.1023/A:1015929109894
Stability of Protein Pharmaceuticals
M. Manning (2004)
10.1016/S0264-410X(98)00241-2
Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.
S. Kim (1999)
Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
B. Sabel (1990)
10.1016/J.ADDR.2004.09.004
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
H. O. Alpar (2005)
10.1016/J.VACCINE.2004.04.022
Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.
A. Stanley (2004)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1080/02652040110055216
Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
M. Frangione-Beebe (2001)
10.1083/JCB.101.6.2124
Occluding junction structure-function relationships in a cultured epithelial monolayer
J. Madara (1985)



This paper is referenced by
Poly (e-caprolactone)/SBA-15 composite biomaterials plasticized with greener additives
A. S. Rosa (2013)
10.1517/17425247.2010.514604
Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery
Nicolas Duceppe (2010)
10.20959/WJPPS20175-8964
FORMULATION AND IN-VITRO CHARACTERIZATION OF BIODEGRADABLE ISONIAZID NANOPARTICLES IN COW URINE
V. S. Babu (2017)
Effect of Cross Linking Agent and Polymer on The Characteristics of Ovalbumin Loaded Alginater Microspheres
D. Hariyadi (2014)
Entwicklung eines PYY-haltigen Nanocarriers zur oralen Verabreichung gegen Adipositas in vitro und ex vivo Systemen
Maria Parowatkin (2017)
10.1002/9780470571224.PSE520
Controlled-Release Systems for Biologics
Mayura Oak (2013)
EFFECT OF CROSS LINKING AGENT AND POLYMER ON THE CHARACTERISTICS OF OVALBUMIN LOADED ALGINATE MICROSPHERES
D. Hariyadi (2014)
Developing a tissue engineering strategy for cleft palate repair
Sasima Puwanun (2014)
10.1016/B978-0-12-384964-9.00011-6
Parenteral Delivery of Peptides and Proteins
H. Agrawal (2011)
10.7150/IJBS.5.622
Krüppel-like family of transcription factors: an emerging new frontier in fat biology
C. Brey (2009)
10.1007/978-3-642-29265-1_10
Nanosized Drug Delivery for Enhancement of Oral Bioavailability
M. Özyazıcı (2012)
10.1002/pat.4836
The electrospun poly(ε‐caprolactone)/fluoridated hydroxyapatite nanocomposite for bone tissue engineering
N. Johari (2020)
10.1002/mabi.201200372
In vivo biological responses to silk proteins functionalized with bone sialoprotein.
S. Gomes (2013)
10.1080/21691401.2017.1345927
Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview
L. Kaur (2018)
10.1111/ics.12017
Biodegradable polymers as encapsulation materials for cosmetics and personal care markets
A. Ammala (2013)
10.1080/21691401.2016.1198360
Assessment of polycaprolacton (PCL) nanocomposite scaffold compared with hydroxyapatite (HA) on healing of segmental femur bone defect in rabbits
H. Eftekhari (2017)
MODEL ANTIGEN OVALBUMIN DENGAN TEKNIK AEROSOLISASI FORMULATION AND EVALUATION OF Ca-ALGINATE MICROSPHERES ENTRAPPING MODEL ANTIGEN PRODUCED BY AEROSOLIZATION TECHNIQUE
D. Hariyadi (2015)
10.3109/02652048.2015.1115900
Encapsulation of cosmetic active ingredients for topical application – a review
Francisca Casanova (2016)
10.4155/tde.15.71
Polymer-based vehicles for therapeutic peptide delivery.
J. Zhang (2015)
A NOVEL APPROACH TO DELIVER THERAPEUTIC AGENTS USING IN SITU FORMING IMPLANT BASED ON SOLVENT INDUCED PHASE SEPARATION TECHNIQUE FOR LONG TERM CONTROLLED RELEASE
Ridhdhesh Jivawala (2017)
10.1081/E-EBPP-120049273
Biodegradable Polymers: Drug Delivery Applications
Satish Shilpi (2015)
10.17169/REFUBIUM-6249
Development of biodegradable implants with specific drug release profiles
J. Teodosic (2016)
Biodegradable polymers: emerging excipients for the pharmaceutical and medical device industries.
B. B. Patel (2013)
10.3109/21691401.2013.809726
Development and characterization of LTA-appended chitosan nanoparticles for mucosal immunization against hepatitis B
N. Mishra (2014)
10.1517/13543771003730425
Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers
N. Mishra (2010)
10.1016/j.vaccine.2012.11.068
Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.
A. Badiee (2013)
Biodegradable polymer: An emerging excipient in pharmaceutical and medical device industry
B. B. Patel (2013)
10.1201/B19038
Handbook of Encapsulation and Controlled Release
M. Mishra (2015)
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Zahra Ghalanbor (2011)
10.1002/term.437
Biological responses to spider silk–antibiotic fusion protein
S. Gomes (2012)
10.1080/15583724.2013.828751
Effect of Physicochemical Properties of Biodegradable Polymers on Nano Drug Delivery
Sonam (2013)
10.1080/08820139.2019.1610889
Poly Lactic-co-Glycolic Acid Nanoparticles Containing Human Gastric Tumor Lysates as Antigen Delivery Vehicles for Dendritic Cell-Based Antitumor Immunotherapy
Chia Kohnepoushi (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar